GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock ...

This Fool wants to make the most of the benefits a Stocks and Shares ISA provides. He's keen on these two stocks. The post I ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

The inoculation campaign is expected to lower the mortality rate in children, as malaria makes up 19 percent of child deaths ...

FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra.

Niger has become the latest West African country to roll out malaria vaccines to try to stifle the potentially deadly disease, an official source told AFP on Friday.

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

NKT2152, a novel HIF2a inhibitor, demonstrates significant efficacy in patients with advanced clear cell renal cell carcinoma ...

AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...

Shields has been vocal about women's wellness and now backs an initiative for women to be aware of an infection that's ...